This article has been updated with comments from an official with the Wilson Center.

NEW YORK (GenomeWeb) – As new synthetic biology technologies come online and as more commercial applications for them move toward the market, more research is needed in several specific areas to investigate the ecological impacts these engineered organisms may have on the environment, according to a new report.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.